TITLE:
Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia

CONDITION:
Bacterial Pneumonia

INTERVENTION:
Tigecycline

SUMMARY:

      To compare the efficacy and safety of the tigecycline regimen with that of the
      imipenem/cilastatin regimen in subjects with nosocomial pneumonia.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 70 Years
Criteria:

        Inclusion Criteria:

          -  Male or female subjects over 18 years of age. Bulgaria Only: Male or female subjects
             over 18 years of age and under 70 years of age.

          -  Subjects known or suspected to have acute hospital-acquired pneumonia.

        Exclusion Criteria:

          -  Presence of any of the following pulmonary conditions: cystic fibrosis; pulmonary
             malignancy (either primary or metastatic); known bronchial-obstructive or post
             obstructive pneumonia; pulmonary abscess; empyema; known or suspected active
             tuberculosis; bronchiectasis; sarcoidosis; known or suspected pulmonary infection
             caused by Pneumocystis carinii, mycobacteria, fungi, parasites, or viruses (Subjects
             with COPD are not excluded)

          -  Suspected or known Legionella infection

          -  Concurrent hemodialysis, hemofiltration, peritoneal dialysis, or plasmapheresis
      
